Completed OBSERVATIONAL NCT03177369

Teicoplanin-based Antimicrobial Therapy in Staphylococcus Aureus Bone and Joint Infection: Tolerance, Efficacy and Experience With Subcutaneous Administration

Sponsor: Hospices Civils de Lyon

Conditions Bone and Joint Infection Staphylococcus Aureus Teicoplanin-based Antimicrobial Therapy

Updated 6 times since 2017 Last updated: Jun 2, 2017 Started: Jan 31, 2015 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Bone and Joint Infection and Staphylococcus Aureus and is currently completed. Hospices Civils de Lyon leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jul 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospices Civils de Lyon

Data source: Hospices Civils de Lyon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lyon, France